A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease (AMBAR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01561053|
Recruitment Status : Active, not recruiting
First Posted : March 22, 2012
Last Update Posted : August 2, 2017
Instituto Grifols, S.A.
Grifols Biologicals Inc.
Information provided by (Responsible Party):
Grifols Biologicals Inc. ( Instituto Grifols, S.A. )
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Active, not recruiting|
|Estimated Primary Completion Date :||December 2017|
|Estimated Study Completion Date :||December 2017|